

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 23.93 | 36.30 | 52.94 | 73 | 56.21 |
| Total Expenses | 30.32 | 37.51 | 54.86 | 60.64 | 54.06 |
| Profit Before Tax | -6.39 | -1.21 | -4.16 | 12.36 | 2.14 |
| Profit After Tax | -5.08 | -1.68 | -2.68 | 11.38 | 1.40 |
| Operating Profit After Depreciation | -6.39 | -0.99 | -1.49 | 12.83 | 3.28 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 2.54 | 2.91 | 3.31 | 2.83 | 4.43 |
| Total Non Current Assets | 4.71 | 8.96 | 8.08 | 3.72 | 16.18 |
| Total Current Assets | 21.05 | 24.68 | 20.08 | 38.23 | 22.54 |
| Total Assets | 25.76 | 33.63 | 28.16 | 41.95 | 38.72 |
| Total Shareholder's Fund | 22.86 | 21.86 | 23.21 | 24.17 | 13.69 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -9.82 | 4.85 | -1.56 | 8.26 | 1.83 |
| Net Cash Used In Investing Activities | 3.07 | -1.79 | -4.28 | -1.13 | -0.31 |
| Net Cash Used In Financing Activities | 0.24 | -1.17 | -2.15 | 1.30 | 3.99 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.88 | 3.55 | 0.84 | 1.03 | 1.12 |
| Total Expenses | 1.31 | 3.53 | 1.24 | 0.68 | 1.02 |
| Profit Before Tax | -0.44 | 0.03 | -2.64 | 0.36 | 0.10 |
| Profit After Tax | -0.44 | 0.02 | -2.62 | 0.36 | 0.10 |
| Operating Profit After Depreciation | -0.44 | 0.03 | -0.40 | 0.36 | 0.12 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 0.14 | 0.10 | 0.12 | 0.33 | 0.26 |
| Total Non Current Assets | 8.85 | 8.79 | 8.81 | 9 | 8.67 |
| Total Current Assets | 0.32 | 3.97 | 0.18 | 2.60 | 2.73 |
| Total Assets | 9.18 | 12.76 | 8.99 | 11.60 | 11.40 |
| Total Shareholder's Fund | 8.49 | 8.93 | 8.90 | 11.52 | 11.16 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 0.07 | -0.03 | -0.08 | 0.55 | 0.27 |
| Net Cash Used In Investing Activities | -0.05 | - | 0.09 | -0.38 | -0.19 |
| Net Cash Used In Financing Activities | - | - | - | -0.14 | -0.09 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 3.60 | 3.21 | 4.31 | 2.92 | 3.50 |
| Total Expenses | 3.38 | 3.63 | 4.19 | 6.24 | 10.07 |
| Profit Before Tax | 0.24 | -0.53 | 0.01 | -3.43 | -5.83 |
| Profit After Tax | -0.36 | -0.54 | 0.02 | -3.43 | -4.11 |
| Operating Profit after Depreciation | 0.39 | -0.40 | 0.14 | -3.31 | -5.70 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 0.07 | 0.13 | 0.09 | 0.85 | 0.23 |
| Total Expenses | 0.24 | 0.14 | 0.20 | 0.79 | 0.39 |
| Profit Before Tax | -0.17 | -0.01 | -0.11 | 0.06 | -0.16 |
| Profit After Tax | -0.17 | -0.01 | -0.12 | 0.06 | -0.17 |
| Operating Profit after Depreciation | -0.17 | -0.01 | -0.11 | 0.06 | -0.16 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
No data available
On 30 May 2026
28 May 2026, 12:48 pm
On 12 February 2026
10 Feb 2026, 11:21 am
On 12 February 2026
20 Jan 2026, 03:46 pm
On 13 November 2025
11 Nov 2025, 02:51 pm
On 30 September 2025
16 Sep 2025, 12:02 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.